AKT1 and AKT2 mutations in lung cancer in a Japanese population

Molecular Medicine Reports

Volumn 1, Issue 5, 2008, Pages 663-666

  Sasaki, Hidefumi ^a   Okuda, Katsuhiro ^a   Kawano, Osamu ^a   Yukiue, Haruhiro ^a   Yano, Motoki ^a   Fujii, Yoshitaka ^a  

^a NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

Author keywords

AKT1; AKT2; Lung cancer; Mutation; R371H

Indexed keywords

AMINO TERMINAL TELOPEPTIDE; B RAF KINASE; EPIDERMAL GROWTH FACTOR RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE;

AKT2 GENE; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; FEMALE; GENE; GENE SEQUENCE; GENETIC ANALYSIS; HUMAN; JAPANESE; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; ONCOGENE K RAS; RNA EXTRACTION; SMOKING; SQUAMOUS CELL CARCINOMA; TUMOR BIOPSY; V AKT MURINE THYMOMA VIRAL ONCOGENE HOMOLOGUE 1 GENE;

MURINAE;

EID: 69449098969     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr_00000009     Document Type: Article

References (27)

1. Ginsberg RJ, Kris K and Armstrong G: Cancer of the lung. In: Principles and Practice of Oncology. 4th edition. Lippincott, Philadelphia, pp673-682, 1993.
2. Vivanco I and Sawyers CL: The phosphatidylinositol 3-kinase AKT pathway in human cancer. Nat Rev Cancer 2: 489-501, 2002. (Pubitemid 37328931)
3. Brognard J, Clark AS, Ni Y and Dennis PA: Akt/protein B is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation. Cancer Res 61: 3986-3997, 2001. (Pubitemid 32720961)
4. David O, Jett J, LeBean H, Dy G, Hughes J, Friedman M and Brody AR: Phospho-Akt overexpression in non-small cell lung cancer confers significant stage-independent survival disadvantage. Clin Cancer Res 10: 6865-6871, 2004. (Pubitemid 39383035)
5. Soung YH, Lee JW, Nam SW, Lee JY, Yoo NJ and Lee SH: Mutational analysis of AKT1, AKT2, and AKT3 genes in common human carcinomas. Oncology 70: 285-289, 2006.
6. Carpten JD, Faber AL, Horn C, et al: A transforming mutation in the pleckstrin homology domain of AKT1 in cancer. Nature 448: 439-444, 2007. (Pubitemid 47123510)
7. Malanga D, Scrima M, De Marco C, et al: Activating E17K mutation in the gene encoding the protein kinase AKT in a subset of squamous cell carcinoma of the lung. Cell Cycle 7: 665-669, 2008.
8. Paez JG, Janne PA, Lee JC, et al: EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 304: 1497-1500, 2004. (Pubitemid 38720929)
9. Endo K, Konishi A, Sasaki H, et al: Epidermal growth factor receptor gene mutation in non-small cell lung cancer using highly sensitive and fast TaqMan PCR assay. Lung Cancer 50: 375-384, 2005. (Pubitemid 43300637)
10. Sasaki H, Shimizu S, Endo K, et al: EGFR and erbB2 mutation status in Japanese lung cancer patients. Int J Cancer 118: 180-184, 2006. (Pubitemid 41681596)
11. Sasaki H, Endo K, Konishi A, et al: EGFR mutation status in Japanese lung cancer patients: genotyping analysis using LightCycler. Clin Cancer Res 11: 2924-2929, 2005. (Pubitemid 40525194)
12. Japan Lung Cancer Society: General Rule for Clinical and Pathological Record of Lung Cancer. 5th edition. Kanhara Press, Tokyo, pp1-177, 1999.
13. Davies MA, Koul D, Dhesi H, et al: Regulation of Akt/PKB activity, cellular growth, and apoptosis in prostate carcinoma cells by MMAC/PTEN. Cancer Res 59: 2551-2556, 1999. (Pubitemid 29269096)
14. Hutchinson J, Jin J, Cardiff RD, Woodgett JR and Muller WJ: Activation of Akt (protein B) in mammary epithelium provides a critical cell survival signal required for tumor progression. Mol Cell Biol 21: 2203-2212, 2001. (Pubitemid 32479640)
15. Campbell RA, Bhat-Nakshatri P, Patel NM, Constantinidou D, Ali S and Nakshatri H: Phosphatidylinositol 3-kinase/Aktmediated activation of estrogen receptor alpha: a new model for anti-estrogen resistance. J Biol Chem 276: 9817-9824, 2001. (Pubitemid 37391881)
16. Moore SM, Rintoul RC, Walker TR, Chilvers ER, Haslett C and Sethi T: The presence of a constitutively active phosphoinositide 3-kinase in small cell lung cancer cells mediates anchorage-independent proliferation via a protein kinase B and p70s6k-dependent pathway. Cancer Res 58: 5239-5247, 1998. (Pubitemid 28521188)
17. Nakashio A, Fujita N, Rokudai S, Sato S and Tsuruo T: Prevention of phosphatidylinositol 3′-kinase-Akt survival signaling pathway during topotecan-induced apoptosis. Cancer Res 60: 5303-5309, 2000. (Pubitemid 30739793)
18. Samuels Y, Wang Z, Bardelli A, et al: High frequency of mutations of the PIK3CA gene in human cancers. Science 304: 554, 2004. (Pubitemid 38541907)
19. Kawano O, Sasaki H, Endo K, et al: PIK3CA mutation status in Japanese lung cancer patients. Lung Cancer 54: 209-215, 2006. (Pubitemid 44764916)
20. Okudera K, Suzuki M, Kageyama S, et al: PIK3CA mutation and amplification in human lung cancer. Pathol Int 57: 664-671, 2007. (Pubitemid 47353042)
21. Stocker H, Andjelkovic M, Oldham S, et al: Living with lethal PIP3 levels: viability of flies lacking PTEN restored by a PH domain mutation in Akt/PKB. Science 295: 2088-2091, 2002. (Pubitemid 34229473)
22. Franke TF, Yang SI, Chan TO, et al: The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell 81: 727-736, 1995.
23. Yuan ZQ, Sun M, Feldman RI, et al: Frequent activation of Akt2 and induction of apoptosis by inhibition of phosphoinositide-3-OH kinase/Akt pathway in human ovarian cancer. Oncogene 19: 2324-2330, 2000. (Pubitemid 30307208)
24. Cheng JQ, Ruggeri B, Klein WM, Sonoda G, Altomare DA, Watson DK and Testa JR: Amplification of AKT2 in human pancreatic cells and inhibition of AKT2 expression and tumorigenecity by antisense RNA. Proc Natl Acad Sci USA 93: 3636-3641, 1996. (Pubitemid 26127592)
25. Xu X, Sakon M, Nagano H, et al: Akt2 expression correlates with prognosis of human hepatocellular carcinoma. Oncol Rep 11: 25-32, 2004.
26. Sasaki H, Kawano O, Endo K, et al: Uncommon V599E mutations in Japanese patients with lung cancer. J Surg Res 133: 203-206, 2006.
27. Sasaki H, Okuda K, Kawano O, et al: Nras and Kras mutation in Japanese lung cancer patients: genotyping analysis using LightCycler. Oncol Rep 18: 623-628, 2007.